It’s the end of an era for global health advocacy. After three decades of illuminating the path to HIV prevention and public health breakthroughs, IAVI Report will cease publication in 2026. This decision, driven by the mounting financial pressures faced by IAVI and countless other non-profits in the sector, marks a somber milestone. But here's where it gets controversial: as funding dries up, what does this mean for the future of independent, science-driven journalism in public health? And this is the part most people miss—the ripple effects of losing such a trusted voice in the fight against infectious diseases.
For 30 years, IAVI Report has been more than just a publication; it’s been a beacon of progress. Starting as a niche newsletter focused on IAVI’s initiatives, it evolved into a vibrant, full-color journal dissecting HIV science and prevention research. Eventually, it transitioned to an online-only format, adapting to the digital age while maintaining its commitment to accuracy and depth. Its sister publication, VAX, though shorter-lived, played a crucial role in bridging the gap between clinical trial sites and communities, demystifying HIV research and the science behind other infectious diseases.
The final article (https://www.iavi.org/?post_type=iavi-report&p=11680) is not just a farewell but a celebration of the optimism, determination, and passion that have fueled IAVI Report’s journey. It’s a reminder that progress, though sometimes fragile, is always worth fighting for. Read the full note from the editor here (https://www.iavi.org/iavi-report/note-from-editor/) to understand the challenges and reflections behind this decision.
But here’s the question we can’t ignore: In an era where misinformation spreads faster than ever, can we afford to lose platforms like IAVI Report? Share your thoughts in the comments—do you think this is a necessary sacrifice in the face of budget constraints, or a dangerous precedent for public health communication? Let’s spark a conversation that matters.
